The present healthcare scenario is such that physicians have the tendency to prescribe more and more medicines as the number of visits increase. Every time a patient visits, the condition worsens instead of becoming better because patients often lose track with so many prescriptions, leading to non-compliance. Research shows that most chronic patients stop medications after a certain period.  There are multiple causes for patient non-compliance – costs, side effects, several prescriptions simultaneously, improper follow-ups, treatment settings, patient characteristics and many more. Pharmaceutical companies are now sourcing more data on non-compliance to identify patterns that raise patient compliance levels. Patient compliance is usually measured by:

  • Collecting data
  • Analysing the data using various methods

Collecting data: Data is conventionally collected directly and indirectly. Direct collection includes primary research, surveys, interviews, focus groups and more. Indirect collection includes secondary research from different authenticated sites. Experts collect data from different medical records, patient records, electronic health records, and summarise the relevant information to find valuable information.

Analysing the data: Experts analyse and customise data after sourcing it from different information sources. They usually source real-time information on patient compliance and particular products, and the behaviour patterns of patients towards the medication

Methods to analyse the data: Experts use innovative data visualization tools and dashboards to analyse patient compliance data. Predictive analysis also helps to analyse the behaviour and needs of patients, which is further helpful to manage patient compliance.

How to improve non-compliance: The best ways to improve non-compliance are to decrease the costs of drugs, improve patient-provider relationships, innovative medications or strips, external devices like smart watches and mobile applications for reminders on drug intake and appointments with doctors.

Though is not easy for pharmaceutical companies to manage records, collect data and customize it for insights on patient compliance, sensible analysis can always help to reach out to patients, improve clinical results and enhance brand performance.

Non-compliance is a major concern for pharmaceutical companies. They are constantly seeking better analytical techniques and newer technologies to overcome this obstacle. Drugs and related therapies offer different challenges. Hence, the approaches also vary. The onus is upon these companies to adapt.


Shivangi Dubey

Business Analyst

Discover the hidden/unattended patients’ segments and thereby access the un-tapped market by better visualization of patient movement, and understanding of treatment perceptions and physician preferences via phamax’ patient journey

Contact our analyst to know more